A nurse in a provider's office is caring for a group of clients who have communicable diseases. Which of the following infections should the nurse report to the state health department?

A) Medical health insurance claims:
Medical health insurance claims are not relevant to the referral for physical therapy. This information is typically handled by billing departments and insurance providers. The focus of a physical therapy referral is on the patient's clinical condition and needs, not their insurance coverage.

B) Physical assessment findings:
This is the most relevant information to include in a referral for physical therapy. The physical assessment findings provide the physical therapist with important details about the client's mobility, strength, range of motion, and other factors that can guide the creation of an individualized therapy plan. These findings help the therapist understand the client's current physical capabilities and limitations.

C) Medications taken prior to admission:
While it is important for the healthcare team to be aware of the medications a client is taking, this information is not as crucial for the physical therapy referral itself. The physical therapist may need to know about medications if they have a direct impact on the client's physical functioning (e.g., sedatives or pain medications), but the primary focus for the referral would be on the physical assessment findings.

D) Family medical history:
Family medical history is typically relevant to a broader health assessment but is not generally included in a referral for physical therapy. The therapist will be more concerned with the client's current physical condition and functional abilities rather than the medical history of the client's family.

A) I have occasional vaginal spotting: Vaginal spotting can occur as a side effect of medroxyprogesterone, especially in the first few months of use. While this should be monitored, it is not an immediate concern that requires urgent reporting unless the spotting becomes heavy or persistent, which could indicate other issues.

B) I have developed brown patches on my face: The development of brown patches on the face (known as melasma) is a known side effect of hormonal contraceptives, including medroxyprogesterone. Although this is an undesirable cosmetic effect, it is not an urgent medical concern that requires immediate attention.

C) I have breast tenderness: Breast tenderness is a common side effect of medroxyprogesterone and other hormonal medications. It is usually mild and resolves over time. While the client should continue to monitor the tenderness, it does not present an immediate risk or require urgent intervention.

D) I have intermittent calf pain: Intermittent calf pain could be a sign of a more serious complication, such as a deep vein thrombosis (DVT), especially since medroxyprogesterone can increase the risk of blood clots. This symptom should be reported immediately to the healthcare provider, as a DVT could potentially lead to a pulmonary embolism if left untreated, which is a life-threatening condition. Therefore, this is the priority finding to report.